Richard R. Kerr
Updates to MAPP project top interstitial cystitis/bladder pain syndrome highlights
The most informative presentations on interstitial cystitis/bladder syndrome at the 2014 AUA annual meeting will be a plenary talk by J. Quentin Clemens, MD, updating attendees on the National Institute of Diabetes and Digestive and Kidney Diseases’ Multidisciplinary Approach to Pelvic Pain project and an abstract providing long-term follow-up on the use of cyclosporine A in patients with refractory IC, according to Philip M. Hanno, MD, MPH.
One-fourth of men drop out of prostate cancer surveillance
About one-fourth of men with slow-growing prostate cancer who undergo active surveillance drop out of the program, according to findings from a relatively small European study.
PDE-5 inhibitor fails to prevent ED after radiation
Among men undergoing radiation therapy for prostate cancer, daily use of the phosphodiesterase type-5 inhibitor tadalafil (Cialis), compared with placebo, did not prevent loss of erectile function, a recently published study found.
Statins show significant benefit in men with erectile dysfunction
Cholesterol-lowering statin drugs are associated with a significant improvement in erectile function, cardiologists reported in a new meta-analysis.
Primary ADT for prostate cancer shows no survival benefit
Primary androgen deprivation therapy in men with localized prostate cancer appears to offer no survival benefit.
AUA names Dr. Wolf Science & Quality Council chair
J. Stuart Wolf, MD, will serve as the first chair of the AUA’s newly created Science & Quality (S&Q) Council, the association announced.
CMS issues two codes for BPH implant procedure
The Centers for Medicare & Medicaid Services has issued two new codes that describe the UroLift implant procedure for the treatment of enlarged prostate in the April 2014 Update of the Hospital Outpatient Prospective Payment System (OPPS).
Drop in PSA screening greatest among urologists
The U.S. Preventive Services Task Force recommendation against routine prostate cancer screening has resulted in a decrease in the number of PSA-based screenings ordered by physicians, with the greatest decline seen among urologists, according to findings of recently published study that one leading prostate cancer expert says raises more questions than it answers.
Studies target BPA, plasticizers in prostate cancer, fecundity
Levels of bisphenol A in men’s urine could be a marker of prostate cancer, and male exposure to other environmental chemicals used in the manufacture of plastics appear to negatively impact time to pregnancy, two separate studies have found.
ICD-10 deadline will not change, CMS head says
One of the AUA’s top legislative priorities for 2014—opposing or deferring implementation of the International Classification of Diseases-10th revision (ICD-10)—appears to be in danger.